Clinical-grade monitoring from a device you already own.
digital health teams feel it every week: the status quo scales cost, not outcomes. There is no clean upgrade path — only rip-and-replace.
Bottom-up, the reachable market clears a nine-figure ceiling before expansion.
digital health budgets are shifting from headcount to platform.
The primitives finally exist to do this at the edge.
A bottom-up motion the incumbents can’t run.
Trial design, results, and regulatory status.
“Pulse is the first at-home tool my cardiology team trusts.”
sensitivity detecting early deterioration in a 12,000-patient trial.